Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies

BackgroundQuality assurance (QA) and quality control (QC) are two quality management processes that are integral to the success of metabolomics including their application for the acquisition of high quality data in any high-throughput analytical chemistry laboratory. QA defines all the planned and systematic activities implemented before samples are collected, to provide confidence that a subsequent analytical process will fulfil predetermined requirements for quality. QC can be defined as the operational techniques and activities used to measure and report these quality requirements after data acquisition.Aim of reviewThis tutorial review will guide the reader through the use of system suitability and QC samples, why these samples should be applied and how the quality of data can be reported.Key scientific concepts of reviewSystem suitability samples are applied to assess the operation and lack of contamination of the analytical platform prior to sample analysis. Isotopically-labelled internal standards are applied to assess system stability for each sample analysed. Pooled QC samples are applied to condition the analytical platform, perform intra-study reproducibility measurements (QC) and to correct mathematically for systematic errors. Standard reference materials and long-term reference QC samples are applied for inter-study and inter-laboratory assessment of data.

[1]  Mark R. Viant,et al.  Training needs in metabolomics , 2015, Metabolomics.

[2]  C A Halterman,et al.  Controlling quality. , 1982, Quintessence of dental technology.

[3]  Royston Goodacre,et al.  Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. , 2011, Chemical Society reviews.

[4]  Tom R. Gaunt,et al.  Metabolic Characterization of a Rare Genetic Variation Within APOC3 and Its Lipoprotein Lipase–Independent Effects , 2016, Circulation. Cardiovascular genetics.

[5]  Bo Wen,et al.  metaX: a flexible and comprehensive software for processing metabolomics data , 2017, BMC Bioinformatics.

[6]  Han Xie,et al.  Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. , 2014, Cell metabolism.

[7]  Royston Goodacre,et al.  Exhaled breath analysis: a review of ‘breath-taking’ methods for off-line analysis , 2017, Metabolomics.

[8]  P. R. Bevington,et al.  Data Reduction and Error Analysis for the Physical Sciences, 2nd ed. , 1993 .

[9]  R. Weinshilboum,et al.  Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine , 2015, Clinical pharmacology and therapeutics.

[10]  Giorgio Pennazza,et al.  A European Respiratory Society technical standard: exhaled biomarkers in lung disease , 2017, European Respiratory Journal.

[11]  Staðlaráð Íslands,et al.  Gæðastjórnunarkerfi : grunnatriði og íðorðasafn = Quality Management Systems : fundamentals and vocabulary. , 2006 .

[12]  Simone Wahl,et al.  Long-Term Stability of Human Plasma Metabolites during Storage at -80 °C. , 2018, Journal of proteome research.

[13]  Dean P. Jones,et al.  High-performance metabolic profiling with dual chromatography-Fourier-transform mass spectrometry (DC-FTMS) for study of the exposome , 2011, Metabolomics.

[14]  Michael Stuart,et al.  Understanding Robust and Exploratory Data Analysis , 1984 .

[15]  Richard D. Beger,et al.  Quality assurance and quality control processes: summary of a metabolomics community questionnaire , 2017, Metabolomics.

[16]  Jerzy Adamski,et al.  Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma. , 2017, Analytical chemistry.

[17]  Coral Barbas,et al.  Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample , 2015, Metabolomics.

[18]  Stacey N. Reinke,et al.  Metabolomics analysis identifies different metabotypes of asthma severity , 2017, European Respiratory Journal.

[19]  Georgios Theodoridis,et al.  UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. , 2009, Journal of proteome research.

[20]  Harold I. Feldman,et al.  Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study , 2016, American Journal of Nephrology.

[21]  Sarah J. Kurley,et al.  MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. , 2014, The Journal of clinical investigation.

[22]  Steve Lowes,et al.  AAPS and US FDA Crystal City VI workshop on bioanalytical method validation for biomarkers. , 2016, Bioanalysis.

[23]  Richard D. Beger,et al.  The New Data Quality Task Group (DQTG): ensuring high quality data today and in the future , 2014, Metabolomics.

[24]  Simon O'Keefe,et al.  A batch correction method for liquid chromatography–mass spectrometry data that does not depend on quality control samples , 2016, Metabolomics.

[25]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[26]  Eurachem.  Guide to quality in analytical chemistry: an aid to accreditation , 2002 .

[27]  D J Hall.  Training needs. , 1982, Medical record and health care information journal.

[28]  William E. Kraus,et al.  Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases: Form and Function , 2012, Circulation.

[29]  L. Brennan,et al.  The role of metabolomics in determination of new dietary biomarkers , 2017, Proceedings of the Nutrition Society.

[30]  Jens Herbig,et al.  Towards standardization in the analysis of breath gas volatiles , 2014, Journal of breath research.

[31]  Ron Wehrens,et al.  Improved batch correction in untargeted MS-based metabolomics , 2016, Metabolomics.

[32]  S H Brooks,et al.  Additive, multiplicative, and mixed analytical errors. , 1978, Clinical chemistry.

[33]  Yi Zhao,et al.  Evaluation of normalization methods for analysis of LC-MS data , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops.

[34]  Joshua D. Knowles,et al.  Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.

[35]  J. Kuligowski,et al.  Intra-batch effect correction in liquid chromatography-mass spectrometry using quality control samples and support vector regression (QC-SVRC). , 2015, The Analyst.

[36]  R. Goodacre,et al.  Exhaled Volatile Organic Compounds of Infection: A Systematic Review. , 2017, ACS infectious diseases.

[37]  Coral Barbas,et al.  Quality assurance procedures for mass spectrometry untargeted metabolomics. a review , 2018, Journal of pharmaceutical and biomedical analysis.

[38]  Stephen E. Stein,et al.  Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. , 2013, Analytical chemistry.

[39]  Lin Shi,et al.  Large-scale untargeted LC-MS metabolomics data correction using between-batch feature alignment and cluster-based within-batch signal intensity drift correction , 2016, Metabolomics.

[40]  E. Want,et al.  Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.

[41]  P. Elliott,et al.  Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping. , 2016, Analytical chemistry.

[42]  I. Wilson,et al.  A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. , 2006, The Analyst.

[43]  Matej Oresic,et al.  Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950–Metabolites in Frozen Human Plasma[S] , 2017, Journal of Lipid Research.

[44]  Frans M van der Kloet,et al.  Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. , 2009, Journal of proteome research.

[45]  Christian Gieger,et al.  Metabolomic markers reveal novel pathways of ageing and early development in human populations , 2013, International journal of epidemiology.

[46]  J. W. Allwood,et al.  A new strategy for MS/MS data acquisition applying multiple data dependent experiments on Orbitrap mass spectrometers in non-targeted metabolomic applications , 2014, Metabolomics.

[47]  J A Kirwan,et al.  Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow , 2013, Analytical and Bioanalytical Chemistry.

[48]  Christina Kluge,et al.  Data Reduction And Error Analysis For The Physical Sciences , 2016 .

[49]  Royston Goodacre,et al.  Taking your breath away: metabolomics breathes life in to personalized medicine. , 2014, Trends in biotechnology.

[50]  Douglas B. Kell,et al.  Molecular phenotyping of a UK population: defining the human serum metabolome , 2014, Metabolomics.

[51]  Warwick B. Dunn,et al.  A new strategy for MS/MS data acquisition applying multiple data dependent experiments on Orbitrap mass spectrometers in non-targeted metabolomic applications , 2014, Metabolomics.

[52]  David Broadhurst,et al.  The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.

[53]  I. Wilson,et al.  Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.

[54]  Yanlong Liu,et al.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease. , 2016, The American journal of pathology.

[55]  Joshua D. Knowles,et al.  Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. , 2009, Analytical chemistry.